Covid vac­cine tests at nurs­ing homes

Irish Examiner - - Business -

Eli Lilly be­gan test­ing its Covid-19 an­ti­body drug in nurs­ing homes in the US, a treat­ment with po­ten­tial to pro­tect vul­ner­a­ble groups that vac­cines may not cover. The trial, dubbed Blaze-2, marks the third phase of test­ing for the mon­o­clonal an­ti­body that Lilly co-de­vel­oped with Cana­dian start-up AbCellera Bi­o­log­ics. It will en­rol up to 2,400 par­tic­i­pants who are ei­ther di­ag­nosed with Covid-19 or at the risk of ex­po­sure. Mean­while, ri­val drug­mak­ers Ab­bVie, Am­gen, and Takeda said they have be­gun treat­ing pa­tients in a trial to quickly show whether a drug from each com­pany can be re­pur­posed and used against Covid-19.

Newspapers in English

Newspapers from Ireland

© PressReader. All rights reserved.